To explore potential novel therapies for ABCB1-mediated MDR ovarian cancer cases in the clinic, we conducted a qHTCS against an ABCB1-overexpressing MDR ovarian cancer cell line, A2780-ADR. The gene discussed is ABCB1; the disease is ovarian cancer.